On Invalid Date, Indaptus Therapeutics (NASDAQ: INDP) reported Q1 2023 earnings per share (EPS) of -$0.51, up 24.39% year over year. Total Indaptus Therapeutics earnings for the quarter were -$4.25 million. In the same quarter last year, Indaptus Therapeutics's earnings per share (EPS) was -$0.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.